Adavosertib
Showing 26 - 44 of 44
Glioblastoma, GBM Trial in Phoenix (AZD1775)
Completed
- Glioblastoma
- GBM
- AZD1775
-
Phoenix, ArizonaBarrow Neurological Institute at St. Joseph's Hospital Medical C
Dec 9, 2020
Triple-negative Metastatic Breast Cancer Trial in Boston (Cisplatin, AZD1775)
Completed
- Triple-negative Metastatic Breast Cancer
-
Boston, MassachusettsDana-Farber Cancer Institute
Oct 29, 2021
Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- AZD4547
- +6 more
-
Los Angeles, California
- +26 more
Oct 17, 2022
Myelofibroses, Acute Myeloid Leukemia, MDS Trial in New York (Combination AZD1775 with AraC, AZD1775 only)
Terminated
- Myelofibroses
- +2 more
- Combination AZD1775 with AraC
- AZD1775 only
-
New York, New YorkNYU Langone Health
May 20, 2020
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours Trial in Canada, United States (AZD 1775)
Completed
- Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
- AZD 1775
-
Fayetteville, Arkansas
- +16 more
Sep 24, 2019
Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,
Recruiting
- Advanced Malignant Solid Neoplasm
- +49 more
- Adavosertib
- +36 more
-
Birmingham, Alabama
- +1429 more
Aug 17, 2022
Adenocarcinoma of the Pancreas Trial in Ann Arbor (MK-1775, Gemcitabine, Radiation Therapy)
Completed
- Adenocarcinoma of the Pancreas
- MK-1775
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Hospital
Feb 13, 2020
Solid Tumors Trial in Worldwide (Wee-1 kinase inhibitor AZD1775)
Completed
- Solid Tumors
- Wee-1 kinase inhibitor AZD1775
-
Bingham Farms, Michigan
- +13 more
Jun 21, 2019
Head and Neck Squamous Cell Carcinoma Trial in Seattle (drug, other, procedure)
Completed
- Head and Neck Squamous Cell Carcinoma
- Cisplatin
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 11, 2019
Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Tumor Trial
Completed
- Chronic Myelomonocytic Leukemia
- +5 more
- Cytarabine
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Aug 15, 2019
Solid Tumours Trial in United States (CYP1A2 (caffeine), CYP2C19 (omeprazole), CYP3A (midazolam))
Completed
- Solid Tumours
- CYP1A2 (caffeine)
- +4 more
-
Bingham Farms, Michigan
- +6 more
Mar 22, 2019
Solid Tumours Trial in France, Netherlands, United Kingdom (Treatment A - AZD1775 administered under fasted conditions,
Completed
- Solid Tumours
- Treatment A - AZD1775 administered under fasted conditions
- Treatment B - AZD1775 administered under fed conditions.
-
Bordeaux Cedex, France
- +6 more
Apr 27, 2018
Advanced Solid Tumours Trial in Australia, Japan, Korea, Republic of (AZD1775, Paclitaxel, carboplatin)
Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer Trial in United States (AZD1775, AZD1775 Matching Placebo,
Terminated
- Previously Untreated Stage IV Non-Squamous Non Small Cell Lung Cancer
- AZD1775
- +3 more
-
Englewood, Colorado
- +7 more
Feb 10, 2017
Previously Treated Non Small Cell Lung Cancer Trial in United States (AZD1775, AZD1775 Placebo, Antimitotic Agent)
Terminated
- Previously Treated Non Small Cell Lung Cancer
- AZD1775
- +3 more
-
Birmingham, Alabama
- +11 more
May 6, 2016